Histochemical study of cardiac mast cells degranulation and collagen deposition: Interaction with the cathecolaminergic system in the rat

European Journal of Histochemistry

Volumn 50, Issue 2, 2006, Pages 133-140

  Facoetti, A ^a   Fallarini, S ^a   Miserere, S ^a   Bertolotti, A ^a   Ferrero, I ^a   Tozzi, R ^a   Gatti, C ^a   Palladini, G ^a   Perlini, S ^a   Nano, Rosanna ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Collagen; Mast cells; Propranolol; Rat; Sympathetic inactivation

Indexed keywords

BETA ADRENERGIC RECEPTOR; COLLAGEN; OXIDOPAMINE; PROPRANOLOL; ADRENERGIC RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CATECHOLAMINERGIC SYSTEM; CELL DENSITY; CELL STRUCTURE; CONTROLLED STUDY; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL DEGRANULATION; NONHUMAN; RAT; ANIMAL; CELL COUNT; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DEGRANULATION; DRUG EFFECT; HEART MUSCLE; HEART VENTRICLE; HISTOLOGY; MAST CELL; PERICARDIUM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; CELL COUNT; CELL DEGRANULATION; COLLAGEN; HEART VENTRICLES; IMMUNOHISTOCHEMISTRY; MALE; MAST CELLS; MYOCARDIUM; OXIDOPAMINE; PERICARDIUM; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; SYMPATHOLYTICS;

EID: 34248140449     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Abd-El-Aleem SA, Morgan C, Ferguson MWJ, McCollum CN, Ireland GW. Spatial distribution of mast cells in chronic venous leg ulcers. Eur J Histochem 2005;49:265-72.
2. Abe M, Kurosawa M, Ishikawa O, Miyachi Y, Kido H. Mast cell tryptase stimulates both human dermal fibroblast proliferation and type I collagen production. Clin Exp Allergy 1998; 28: 1509-17.
3. Artico M., Iannetti G., Tranquilli Reali F.M., Milinovsky L., Cavallotti C. Nerve fibers-mast cells correlation in the rat pleura. Respir Physiol 1998; 113:181-8.
4. Barnes P.J. Are mast cells still important in asthma? Rev Fr Allergol Immunol Clin 2002; 42:20-7.
5. Bergerot A., Reynier-Rebuffel A.M., Callebert J., Aubineau P. Long-term superior cervical sympathectomy induces mast cell hyperplasia and increases histamine and serotonin content in the rat dura mater. Neuroscience 2000; 96: 205-13.
6. Bradding P., Holgate S.T. Immunopathology and human mast cell cytokines. Crit Rev Oncol Hematol 1999; 31:119-33.
7. Bristow MR. β-Adrenergic Receptor Blockade in Chronic Heart Failure. Circulation. 2000; 101:558-69.
8. Brower GL, Chancey AL, Thanigaraj S, Matsubara BB, Janicki JS. Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity. Am J Physiol Heart Circ Physiol, 2002; 283: H518-25.
9. Brown JK, Leff AR, Frey MJ, Reed BR, Lazarus SC, Shields R et al. Characterization of tracheal mast cell reactions in vivo. Inhibition by a beta-adrenergic agonist. Am Rev Respir Dis 1982; 126:842-8.
10. Chong LK, Cooper E, Vardey CJ, Peachell PT. Salmeterol inhibition of mediator release from human lung mast cells by β-adrenoceptor-dependent and independent mechanisms. Br J Pharmacol 1998; 123:1009-15.
11. Estensen RD. What is the role of myocardial mast cells? Hum Pathol 1985;16:536-8
12. Ferrari AU, Franzelli C, Daffonchio A, Perlini S, Dirienzo M. Sympathovagal interplay in the control of overall blood pressure variability in unanesthetized rats. Am J Physiol 1996;270:H2143-8.
13. Hatamochi A, Fujiwara K, Ueki H. Effects of histamine on collagen synthesis by cultured fibroblasts derived from guinea pig skin. Arch Dermatol Res 1985;277:60-4.
14. Hara M, Matsumori A, Ono K, Kido H, Hwang MW, Miyamoto T, et al. Mast cells cause apoptosis of cardiomyocytes and proliferation of other intramyocardial cells in vitro. Circulation 1999;100:1443-9.
15. Huang M, Pang X, Letourneau R, Boucher W, Theoharides TC. Acute stress induces cardiac mast cell activation and histamine release, effects that are increased in Apolipoprotein E knockout mice. Cardiovasc Res 2002;55:150-60.
16. Johnson M. Effects of b2-agonists on resident and infiltrating inflammatory cells. J Allergy Clin Immunol. 2002; 110, S282-90.
17. Long CS, Brown RD. The cardiac fibroblast, another therapeutic target for mending the broken heart? J Mol Cell Cardiol 2002; 34:1273-8.
18. Marone G, de Crescenzo G, Adt M, Patella V, Arbustini E, Genovese A. Immunological characterization and functional importance of human heart mast cells. Immunopharmacol 1995; 31:1-18.
19. Murray DB, Gardner JD, Brower GL, Janicki JS. Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats. Am J Physiol Heart Circ Physiol 2004; 287: 2295-9.
20. Nechushtan H and Razin E. Regulation of mast cell growth and proliferation. Crit Rev Oncol Hematol 1996; 23: 131-50.
21. Palladini G., Tozzi R., Perlini S. Cardiac mast cells in the transition to heart failure: innocent bystanders or key actors? J Hypertens. 2003; 21: 1823-5.
22. Panizo A, Mindan FJ, Galindo M., Cenarruzabeitia E, Hernandez M, Diez J. Are mast cells involved in hypertensive heart disease? J Hypertens. 1995; 13:1201-8.
23. Patella V, Marino I, Arbustini E, Lamparter-Schummert B, Verga L, Adt M, et al. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 1998; 17;97:971-8.
24. Perlini S, Palladini G, Ferrero I, Tozzi R, Fallarini S, Facoetti A. et al. Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy. Hypertension 2005; 46: 1213-1218.
25. Petrovic D, Zorc M, Zorc-Pleskovic R, Vraspir-Porenta O. Morphometrical and stereological analysis of myocardial mast cells in myocarditis and dilated cardiomyopathy. Folia Biol (Praha) 1999; 45:63-6.
26. Puxeddu I, Levi-Schaffer F. Mast cells and tissue remodelling. Rev Fr Allergol Immunol Clin 2002; 42:16-8.
27. Scola AM, Chong LK, Suvarna SK, Chess-Williams R, Peachell PT Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol. Br J Pharmacol 2004; 14:163-71.
28. Shiota N, Rysa J, Kovanen PT, Ruskoaho H, Kokkonen JO, Lindstedt KA. A role for cardiac mast cells in the pathogenensis of hypertensive heart disease. J Hypertens 2003; 21:1935-44.
29. Stewart JA Jr, Wei CC, Brower GL, Rynders PE, Lucchesi PA, Dell'Italia L.J, et al. Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodelling in mitral regurgitation in the dog. J Mol Cell Cardiol., 2003; 35: 311-9.
30. Willenheimer R. Left ventricular remodelling and dysfunction. Can the process be prevented? Int J Cardiol 2000; 72: 143-50.